strategic alternatives
Relmada Therapeutics Considers Strategic Alternatives Following Depression Drug Setbacks
Relmada Therapeutics, depression drug, REL-1017, strategic alternatives, sale, major depressive disorder, NMDA receptor blocker
Cyclacel Pharmaceuticals Seeks Financial Lifeline Amidst Cash Crunch
Cyclacel Pharmaceuticals, financial challenges, cost reduction, strategic alternatives, Nasdaq delisting risk, cancer medicine development
Marinus Pharmaceuticals to Reduce Workforce and Explore Strategic Alternatives Following Disappointing Trial Results
Marinus Pharmaceuticals, workforce reduction, strategic alternatives, Ztalmy trial, pharmaceutical industry, biotech layoffs
Gritstone Bio Files for Chapter 11 Bankruptcy, Seeks Strategic Alternatives to Preserve Clinical Research
Gritstone Bio, Chapter 11 bankruptcy, strategic alternatives, clinical research, vaccine development, oncology, infectious diseases
Gritstone Bio Explores Strategic Alternatives Amid Financial Strains and Mixed Cancer Vaccine Trial Results
Gritstone Bio, GRANITE, cancer vaccine, strategic alternatives, financial challenges, Phase 2 trial results
Entero Therapeutics Faces Financial Struggles, Lays Off Most Staff Amidst Debt Crisis
Entero Therapeutics, financial struggles, layoffs, debt crisis, creditors, strategic alternatives
MEI Pharma’s Leadership Shakeup: CEO and Medical Head Step Down Amidst Wind-Down Considerations
MEI Pharma, wind down, CEO, medical head, strategic alternatives